Related Experiment Video
Updated: Sep 24, 2025
Generation of Oligodendrocytes and Oligodendrocyte-Conditioned Medium for Co-Culture Experiments
Published on: February 9, 2020
MicroRNAs in oligodendrocyte development and remyelination
Clarissa Ngo1,2, Rashmi Kothary1,3,4,5
1Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Abstract:
Oligodendrocytes are the glial cells responsible for the formation of myelin around axons of the central nervous system (CNS). Myelin is an insulating layer that allows electrical impulses to transmit quickly and efficiently along neurons. If myelin is damaged, as in chronic demyelinating disorders such as multiple sclerosis (MS), these impulses slow down. Remyelination by oligodendrocytes is often ineffective in MS, in part because of the failure of oligodendrocyte precursor cells (OPCs) to differentiate into mature, myelinating oligodendrocytes. The process of oligodendrocyte differentiation is tightly controlled by several regulatory networks involving transcription factors, intracellular signaling pathways, and extrinsic cues. Understanding the factors that regulate oligodendrocyte development is essential for the discovery of new therapeutic strategies capable of enhancing remyelination. Over the past decade, microRNAs (miRNAs) have emerged as key regulators of oligodendrocyte development, exerting effects on cell specification, proliferation, differentiation, and myelination. This article will review the role of miRNAs on oligodendrocyte biology and discuss their potential as promising therapeutic tools for remyelination.
Insights
MicroRNAs (miRNAs) are crucial regulators of oligodendrocyte development. Understanding their role is key to developing new therapies for remyelination in diseases like multiple sclerosis (MS).
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Oligodendrocytes produce myelin, essential for rapid nerve impulse transmission in the central nervous system (CNS).
- Demyelinating diseases like multiple sclerosis (MS) impair nerve function due to myelin damage and failed remyelination.
- Oligodendrocyte precursor cells (OPCs) often fail to mature, hindering effective remyelination in MS.
Purpose of the Study:
- To review the critical role of microRNAs (miRNAs) in regulating oligodendrocyte development.
- To explore the potential of miRNAs as therapeutic targets for enhancing remyelination.
Main Methods:
- Review of existing literature on miRNA regulation of oligodendrocyte biology.
- Analysis of miRNA involvement in cell specification, proliferation, differentiation, and myelination.
- Discussion of therapeutic strategies targeting miRNAs for remyelination.
Main Results:
- MicroRNAs (miRNAs) are identified as key regulators influencing multiple stages of oligodendrocyte development.
- Dysregulation of miRNAs contributes to impaired oligodendrocyte differentiation and remyelination.
- miRNAs impact oligodendrocyte precursor cell (OPC) fate and myelin production.
Conclusions:
- MicroRNAs (miRNAs) are vital for normal oligodendrocyte function and myelin maintenance.
- Targeting miRNAs offers a promising therapeutic avenue for promoting remyelination in demyelinating disorders.
- Further research into miRNA-mediated pathways can unlock novel treatments for CNS repair.
More Related Videos
11:11Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
Published on: February 17, 2016
08:57Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
Related Concept Videos
01:15Neurogenesis and Regeneration of Nervous Tissue
01:22MicroRNAs
01:25Nervous Tissue: Myelin
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...